| | ENG

For Investigators Only

UCB-IS-01 UCBMC Transplant for Stroke Phase I Trial
The study is to assess the safety and possible efficacy of umbilical cord blood mononuclear cells (UCBMC) in the treatment of chronic ischemic stroke. The study site is open for subject recrutiment.

Study Sites: the Chinese University of Hong Kong Prince of Wales Hospital and the University of Hong Kong Queen Mary Hospital

Principal Investigators: Wai Sang POON and Gilberto LEUNG

No. of Subjects (Estimated): 12

Sponsorship: Stemcyte Inc.

For more information, please refer to:

Clinicaltrials.gov: NCT01673932

What should I do if I would like to participate in the trials of ChinaSCINet?
To learn as much as possible about the clinical trial and then contact the investigator directly. You may also leave your basic information and contact here (Submit a Form). The investigators may retrieve the data and contact you if they think you might be suitable candidate for the trial.

To read more:

About Clinical Research

About Lithium and Cord Blood Cells

Copyright © 2020. CHINASCINET
About Us | SCI Info | Studies | Events | ISCITT | Contact